Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
-0.25%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
4.12B
Dividend Yield
0.00%
P/E Ratio
33.25
EPS
3.11
Revenue
290.51M
Avg. Volume
224.37K

Recently from Cashu

publisher logo
Cashu

Krystal Biotech Leadership's Insider Transactions Signal Strong Growth Confidence

3 days ago
publisher logo
Cashu

Insider Transactions at Krystal Biotech (KRYS) Signal Confidence in Future Innovations

5 days ago
publisher logo
Cashu

Krystal Biotech's Role in Advancing Gene Therapies for Rare Diseases

2 months ago
Stocks
Health Care
krys
Krystal Biotech
KRYS
+1.58 (+1.11%)
142.925
USD
At close at Jul 03, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials

About

What does KRYS do?
Krystal Biotech, based in Pittsburgh, focuses on developing genetic medicines for diseases with high unmet needs, employing 229 staff since its IPO in September 2017. Its products include VYJUVEK for DEB and others targeting cystic fibrosis and solid tumors.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Pennsylvania, USA
Website
http://www.krystalbio.com